Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002316069 | SCV000847543 | benign | Inborn genetic diseases | 2018-01-25 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000909352 | SCV001054152 | likely benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000909352 | SCV001757144 | benign | not provided | 2020-01-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003338754 | SCV004049799 | likely benign | Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome | 2023-04-11 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000909352 | SCV004124636 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | POGZ: BP4, BS2 |
Prevention |
RCV003953268 | SCV004768890 | benign | POGZ-related condition | 2024-01-16 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |